Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Patient Education
Share your love
2023 Recap: Top 15 Ophthalmic Medical Devices
In a groundbreaking year for ophthalmic advancements, 2023 has witnessed the launch of cutting-edge medical devices that promise to reshape the landscape of eye care. From augmented reality headsets to innovative surgical systems, the field is experiencing a wave of…
A Comprehensive Guide for Workplace Eye Wellness Month
In the modern workplace, maintaining eye health has become increasingly crucial, especially as many professions demand prolonged periods of screen time. Recognizing the significance of this issue, Workplace Eye Wellness Month is observed to raise awareness about the importance of…
GRF Allocates $2.5M Grant for Glaucoma Research
The Glaucoma Research Foundation (GRF) announced an unprecedented $2.5 million allocation in annual research grants, marking the most significant investment in its 46-year history dedicated to pioneering efforts towards treating glaucoma and vision loss. Understanding Glaucoma and Its Impact Glaucoma…
OcuTerra’s Nesvategrast Misses Mark in Diabetic Retinopathy Trial
OcuTerra Therapeutics announced the topline results from its phase 2 DR:EAM (Diabetic Retinopathy: Early Active Management) clinical trial, evaluating the efficacy of nesvategrast (OTT166). Nesvategrast, an innovative RGD integrin inhibitor formulated as an eye drop, was under investigation for its…
AI Detects Retinopathy of Prematurity with 100% Accuracy
In a study published in JAMA Ophthalmology, researchers from Oregon Health & Science University (OHSU) alongside international collaborators have unveiled an artificial intelligence (AI) technology capable of independently detecting all severe cases of a condition leading to blindness in prematurely…
Can I Use Eye Drops While Fasting?
In the period of Ramadan, a time when millions around the globe engage in fasting from sunrise to sunset, questions often arise about how certain health practices, such as the use of eye drops, fit within the fasting rules. With…
MediPrint Finalizes Glaucoma Contact Lens Study
MediPrint Ophthalmics has successfully completed its SIGHT-2 phase 2b study, showcasing the efficacy of its innovative product, LL-BMT1, against a control group using bimatoprost 0.01% ophthalmic solution. LL-BMT1, a preservative-free, weekly drug-eluting contact lens, utilizes the company’s 3D printing technology,…
Novel Gene Editing Breakthrough for Eye Conditions
Researchers at the Broad Institute of MIT and Harvard have made a breakthrough in gene editing technology, introducing a new method for delivering prime editing tools into cells of living animals. This advancement, detailed in a study published in Nature…
Vital Tears Names Joseph Tauber, MD as CMO
Vital Tears, known for its innovative autologous serum tears, is excited to announce the appointment of Joseph Tauber, MD, to the role of Chief Medical Officer (CMO). This strategic addition aims to fortify the company’s commitment to leading-edge research, physician…
The Link Between Cortical Blindness and Schizophrenia
Blindness and schizophrenia are two distinct conditions that, at first glance, may seem unrelated. However, emerging research indicates a fascinating and complex relationship between the two, suggesting that congenital or early-life blindness may significantly reduce the risk of developing schizophrenia.…